These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


254 related items for PubMed ID: 29565434

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. CSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancer.
    Wang X, Osada T, Wang Y, Yu L, Sakakura K, Katayama A, McCarthy JB, Brufsky A, Chivukula M, Khoury T, Hsu DS, Barry WT, Lyerly HK, Clay TM, Ferrone S.
    J Natl Cancer Inst; 2010 Oct 06; 102(19):1496-512. PubMed ID: 20852124
    [Abstract] [Full Text] [Related]

  • 4. A novel approach for targeted elimination of CSPG4-positive triple-negative breast cancer cells using a MAP tau-based fusion protein.
    Amoury M, Mladenov R, Nachreiner T, Pham AT, Hristodorov D, Di Fiore S, Helfrich W, Pardo A, Fey G, Schwenkert M, Thepen T, Kiessling F, Hussain AF, Fischer R, Kolberg K, Barth S.
    Int J Cancer; 2016 Aug 15; 139(4):916-27. PubMed ID: 27037627
    [Abstract] [Full Text] [Related]

  • 5. 5-FU resistant EMT-like pancreatic cancer cells are hypersensitive to photochemical internalization of the novel endoglin-targeting immunotoxin CD105-saporin.
    Lund K, Olsen CE, Wong JJW, Olsen PA, Solberg NT, Høgset A, Krauss S, Selbo PK.
    J Exp Clin Cancer Res; 2017 Dec 19; 36(1):187. PubMed ID: 29258566
    [Abstract] [Full Text] [Related]

  • 6. The novel EpCAM-targeting monoclonal antibody 3-17I linked to saporin is highly cytotoxic after photochemical internalization in breast, pancreas and colon cancer cell lines.
    Lund K, Bostad M, Skarpen E, Braunagel M, Kiprijanov S, Krauss S, Duncan A, Høgset A, Selbo PK.
    MAbs; 2014 Dec 19; 6(4):1038-50. PubMed ID: 24525727
    [Abstract] [Full Text] [Related]

  • 7. 212Pb-Labeled Antibody 225.28 Targeted to Chondroitin Sulfate Proteoglycan 4 for Triple-Negative Breast Cancer Therapy in Mouse Models.
    Kasten BB, Oliver PG, Kim H, Fan J, Ferrone S, Zinn KR, Buchsbaum DJ.
    Int J Mol Sci; 2018 Mar 21; 19(4):. PubMed ID: 29561763
    [Abstract] [Full Text] [Related]

  • 8. Multi-modality therapeutics with potent anti-tumor effects: photochemical internalization enhances delivery of the fusion toxin scFvMEL/rGel.
    Selbo PK, Rosenblum MG, Cheung LH, Zhang W, Berg K.
    PLoS One; 2009 Aug 19; 4(8):e6691. PubMed ID: 19690617
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Light-triggered, efficient cytosolic release of IM7-saporin targeting the putative cancer stem cell marker CD44 by photochemical internalization.
    Bostad M, Kausberg M, Weyergang A, Olsen CE, Berg K, Høgset A, Selbo PK.
    Mol Pharm; 2014 Aug 04; 11(8):2764-76. PubMed ID: 24960585
    [Abstract] [Full Text] [Related]

  • 12. CSPG4 in cancer: multiple roles.
    Wang X, Wang Y, Yu L, Sakakura K, Visus C, Schwab JH, Ferrone CR, Favoino E, Koya Y, Campoli MR, McCarthy JB, DeLeo AB, Ferrone S.
    Curr Mol Med; 2010 Jun 04; 10(4):419-29. PubMed ID: 20455858
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Photochemically stimulated drug delivery increases the cytotoxicity and specificity of EGF-saporin.
    Weyergang A, Selbo PK, Berg K.
    J Control Release; 2006 Mar 10; 111(1-2):165-73. PubMed ID: 16466823
    [Abstract] [Full Text] [Related]

  • 16. Photochemical internalization of CD133-targeting immunotoxins efficiently depletes sarcoma cells with stem-like properties and reduces tumorigenicity.
    Stratford EW, Bostad M, Castro R, Skarpen E, Berg K, Høgset A, Myklebost O, Selbo PK.
    Biochim Biophys Acta; 2013 Aug 10; 1830(8):4235-43. PubMed ID: 23643966
    [Abstract] [Full Text] [Related]

  • 17. T lymphocytes redirected against the chondroitin sulfate proteoglycan-4 control the growth of multiple solid tumors both in vitro and in vivo.
    Geldres C, Savoldo B, Hoyos V, Caruana I, Zhang M, Yvon E, Del Vecchio M, Creighton CJ, Ittmann M, Ferrone S, Dotti G.
    Clin Cancer Res; 2014 Feb 15; 20(4):962-71. PubMed ID: 24334762
    [Abstract] [Full Text] [Related]

  • 18. CSPG4 as a target for the specific killing of triple-negative breast cancer cells by a recombinant SNAP-tag-based antibody-auristatin F drug conjugate.
    Mungra N, Biteghe FAN, Malindi Z, Huysamen AM, Karaan M, Hardcastle NS, Bunjun R, Chetty S, Naran K, Lang D, Richter W, Hunter R, Barth S.
    J Cancer Res Clin Oncol; 2023 Oct 15; 149(13):12203-12225. PubMed ID: 37432459
    [Abstract] [Full Text] [Related]

  • 19. Thymoquinone Inhibits Proliferation and Migration of MDA-MB-231 Triple Negative Breast Cancer Cells by Suppressing Autophagy, Beclin-1 and LC3.
    Ünal TD, Hamurcu Z, Delibaşı N, Çınar V, Güler A, Gökçe S, Nurdinov N, Ozpolat B.
    Anticancer Agents Med Chem; 2021 Oct 15; 21(3):355-364. PubMed ID: 32767958
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.